Sarepta Therapeutics Inc logo

Sarepta Therapeutics Inc

NEW
FRA:AB3A (USA)   Ordinary Shares
€ 13.3 -0.62 (-4.45%) Jul 29
At Loss
P/B:
1.09
Market Cap:
€ 1.44B ($ 1.66B)
Enterprise V:
€ 1.78B ($ 2.05B)
Volume:
3.00
Avg Vol (2M):
164.00
Trade In:

Sarepta Therapeutics Inc (FRA:AB3A) Dividend

Sarepta Therapeutics Inc (FRA:AB3A) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:AB3A Dividend

Does Sarepta Therapeutics Inc (FRA:AB3A) pay a dividend?

Sarepta Therapeutics Inc (FRA:AB3A) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Sarepta Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Sarepta Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -6.1% over the past 3 years.

What are dividend-paying alternatives to Sarepta Therapeutics Inc?

For dividend-paying alternatives in Sarepta Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.